NCT02202746 2020-06-23A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast CancerClovis Oncology, Inc.Phase 2 Terminated178 enrolled 20 charts
NCT02109016 2019-07-29A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic AlterationsClovis Oncology, Inc.Phase 2 Terminated18 enrolled